- 4 - 
The National Aeronautics and Space Administration representative, 
Dr. Young, reported that there is no current or planned recombinant 
DNA research activity but that NASA is supporting (mostly through the 
grant mechanism) related work such as nuclear transplantation and poly- 
peptide synthesis. NASA conducts its own peer review but suggested 
need for a centralized review for the evaluation of biohazards, but not 
of scientific merit, to insure uniform and high quality implementation 
of the NIH guidelines. 
The National Science Foundation, represented by Dr. Herman Lewis, accepts 
the NIH guidelines in toto except for the role of the NIH study sections. 
Two documents have been formulated, but not yet approved, to facilitate 
the implementation of the guidelines. The first of these is a letter to 
universities outlining the guidelines, the responsibilities of all 
Involved in recombinant DNA research, and a format to be followed in 
future proposals. The second document, addressed to NSF program personnel, 
recommends the appropriate containment levels for various types of projects 
and also establishes a coding system for computerization of activities. 
In addition, an Office of Recombinant DNA Research has been formed to 
maintain a detailed registry of relevant activities. 
While recognizing the NIH as the lead agency, the NSF stated that it 
wants to establish its own appellate system. No such mechanism has yet 
been decided upon, but there is support for the establishment of a 
committee of consultants. Channels of communication have been opened 
[ 243 ] 
